Literature DB >> 1335643

Persistence of vaccine-induced antibody to hepatitis A virus.

G Wiedermann1, F Ambrosch, F E André, E D'Hondt, A Delem, A Safary.   

Abstract

A level of 10 mIU hepatitis A antibodies/ml as measured by ELISA is believed to be the minimal protective concentration. If this level is considered, the mean persistence of vaccine induced antibodies is approximately 10-11 years after booster dose, 6-7 years if only the primary doses are given and 5-6 years if the minimal individual titre is taken into account.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335643     DOI: 10.1016/0264-410x(92)90566-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Preventing hepatitis A infections. National Advisory Committee on Immunization statement. Laboratory Centre for Disease Control.

Authors: 
Journal:  Can Fam Physician       Date:  1995-07       Impact factor: 3.275

Review 2.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

Review 3.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 4.  Infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

Review 5.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 6.  Safety and effectiveness of the new inactivated hepatitis A virus vaccine.

Authors:  J Furesz; D W Scheifele; L Palkonyay
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

7.  Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany.

Authors:  Kai Michaelis; Christina Poethko-Müller; Ronny Kuhnert; Klaus Stark; Mirko Faber
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.